a year ago
VKTX
AnalystsRoger SongRoger Song's Stock Forecasts
AnalystsRoger Song
Analyst Ranking
Bottom 1%
#4839 out of 4862 analysts
Average Return
-29.66%
Win Rate
23%8 out of 35
Risk vs Reward
Poor
Good
Roger Song's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Sutro Biopharma IncSTRO | +92.81% | $11.27 | $21.72 | 2020-09-02 - 2021-08-31 | Strong Buy |
Atyr Pharma IncATYR | +87.43% | $1.75 | $3.28 | 2024-09-05 - 2025-04-21 | Strong Buy |
Kinnate Biopharma IncKNTE | +76.67% | $1.50 | $2.65 | 2023-09-19 - 2024-04-02 | Strong Buy |
Nektar TherapeuticsNKTR | +49.66% | $1.49 | $0.75 | 2023-02-24 - 2023-05-10 | Sell |
Tourmaline Bio IncTRML | +9.05% | $20.00 | $21.81 | 2023-12-15 - 2024-12-13 | Strong Buy |
Roger Song Analyst Color
Get additional color on Roger Song's coverage of popular stocks
Roger Song's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nektar TherapeuticsNKTR | 5 | Strong Buy | $2.00 | +219.49% | Upgrades | 11 days ago |
Akebia Therapeutics IncAKBA | 1 | Strong Buy | $6.00 | +189.86% | Initiates Coverage On | 21 days ago |
Sana Biotechnology IncSANA | 1 | Strong Buy | $7.00 | +340.25% | Initiates Coverage On | a month ago |
Krystal Biotech IncKRYS | 1 | Strong Buy | $245.00 | +51.32% | Initiates Coverage On | 2 months ago |
Wave Life Sciences LtdWVE | 1 | Strong Buy | $26.00 | +324.84% | Initiates Coverage On | 2 months ago |
Igm Biosciences IncIGMS | 2 | Hold | $2.00 | +56.25% | Downgrades | 3 months ago |
Bioage Labs IncBIOA | 2 | Hold | $7.00 | +74.13% | Downgrades | 4 months ago |
Replimune Group IncREPL | 1 | Strong Buy | $19.00 | +116.77% | Maintains | 5 months ago |
Kura Oncology IncKURA | 2 | Strong Buy | $28.00 | +353.07% | Maintains | 5 months ago |
Aclaris Therapeutics IncACRS | 1 | Strong Buy | $7.00 | +519.47% | Upgrades | 5 months ago |
Disc Medicine IncIRON | 1 | Strong Buy | $89.00 | +111.60% | Initiates Coverage On | 6 months ago |
Novavax IncNVAX | 2 | Strong Buy | $25.00 | +315.97% | Maintains | 6 months ago |
Nurix Therapeutics IncNRIX | 1 | Strong Buy | $41.00 | +288.63% | Initiates Coverage On | 6 months ago |
Zenas Biopharma IncZBIO | 1 | Strong Buy | $35.00 | +258.97% | Initiates Coverage On | 6 months ago |
Kiniksa Pharmaceuticals International PLCKNSA | 1 | Strong Buy | $40.00 | +99.50% | Initiates Coverage On | 7 months ago |
Atyr Pharma IncATYR | 1 | Strong Buy | $9.00 | +174.39% | Initiates Coverage On | 8 months ago |
Vaxcyte IncPCVX | 1 | Strong Buy | $129.00 | +324.48% | Maintains | 8 months ago |
Cytomx Therapeutics IncCTMX | 2 | Strong Buy | $8.00 | +966.67% | Upgrades | a year ago |
Nuvalent IncNUVL | 1 | Strong Buy | $97.00 | N/A | Initiates Coverage On | a year ago |
Tourmaline Bio IncTRML | 2 | Strong Buy | $72.00 | N/A | Maintains | a year ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | a year ago |
Kinnate Biopharma IncKNTE | 2 | Strong Buy | $2.00 | N/A | Maintains | 2 years ago |
Altimmune IncALT | 1 | Strong Buy | $35.00 | N/A | Maintains | 3 years ago |
Prelude Therapeutics IncPRLD | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 3 years ago |
Whitehawk Therapeutics IncWHWK | 1 | Strong Buy | $675.00 | N/A | Initiates Coverage On | 3 years ago |
Corvus Pharmaceuticals IncCRVS | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 3 years ago |
Glycomimetics IncGLYC | 1 | Strong Buy | $4.00 | N/A | Upgrades | 3 years ago |
Atreca IncBCEL | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Molecular Templates IncMTEM | 1 | Strong Buy | $315.00 | N/A | Initiates Coverage On | 5 years ago |
Sutro Biopharma IncSTRO | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.